Axsome Therapeutics, Inc.
SEC CIK 1579428 · AXSM · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jeffs Roger | Director | filed 2015 - 2026 |
| Saad Mark E | Director | filed 2015 - 2026 |
| Mahony Susan | Director | filed 2023 - 2026 |
| Coleman Mark | Director | filed 2015 - 2026 |
| Tabuteau Herriot | Director · Chief Executive Officer | filed 2015 - 2026 |
| Potter Myrtle S | Director | filed 2017 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Pizzie Nick | Chief Financial Officer | filed 2018 - 2026 |
| Jacobson Mark L. | Chief Operating Officer | filed 2020 - 2026 |
| Murdock Hunter R. | General Counsel | filed 2022 - 2026 |
| Maizel Ari | Chief Commercial Officer | filed 2024 - 2026 |
| Marek David C | Chief Commercial Officer | filed 2019 - 2020 |
| Golubieski John | Chief Financial Officer | filed 2017 - 2017 |
| Ames Constance | Vice President, Finance | filed 2015 - 2017 |
| Kaye Randall | Chief Medical Officer | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.